Latanoprost Viatris

Latanoprost, the active ingredient in Latanoprost Viatris, is a prostaglandin F2α analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for open‑angle glaucoma and ocular hypertension in adults. GNH USA supplies Latanoprost Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog used to manage conditions that require reduction of intra‑ocular pressure. - Open‑angle glaucoma: lowers intra‑ocular pressure to help prevent optic nerve damage. - Ocular hypertension: reduces eye pressure to lower the risk of developing glaucoma.

Latanoprost may cause ocular and peri‑ocular reactions, most of which are mild and reversible.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Increased eyelash growth: longer, thicker lashes. - Iris pigmentation: gradual darkening of the iris color. - Eye irritation: burning or stinging sensation. - Blurred vision: temporary visual disturbance. - Periorbital skin darkening: mild hyperpigmentation of skin around the eye.

Serious or Rare Side Effects: - Uveitis: inflammation of the uveal tract requiring medical attention. - Severe allergic reaction: swelling, rash, or difficulty breathing. - Ocular inflammation: marked redness, pain, or discharge. - Corneal edema: swelling of the cornea affecting vision. - Persistent eye pain: may indicate underlying complication. - Vision loss: rare but requires immediate evaluation.

Before using Latanoprost, consider the following safety measures. - Pregnancy: safety not established; avoid use unless benefits outweigh risks. - Breastfeeding: unknown excretion in milk; consult a healthcare professional. - Pre‑existing eye conditions: assess for inflammation or infection before initiation. - Concomitant ocular medications: evaluate potential additive effects on intra‑ocular pressure. - Contact lens wearers: remove lenses before instillation and wait before reinserting. - Store at below 25°C: keep in the original container, protect from light and moisture.

Latanoprost can interact with other ocular agents, influencing efficacy or safety.

Major Interactions (Avoid): - Other prostaglandin analogs: additive IOP‑lowering effect may cause excessive pressure reduction. - Cycloplegic agents: may diminish Latanoprost’s IOP‑lowering response.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce drug effectiveness. - Non‑steroidal anti‑inflammatory eye drops: monitor for irritation. - Systemic beta‑blockers: assess overall IOP control when combined with other glaucoma therapies.